Otsuka F, Joner M, Prati F, Virmani R, Narula J. Careers. Given the similar improvement in prognostic value compared to risk factor only models (Table 2) and similar increases in absolute mortality rates, the attenuation of HR does not limit the clinical utility of using CAC scores for risk stratification in statin users.17. 2018 Sep 21;39(36):3369-3376. doi: 10.1093/eurheartj/ehy433. Clinical studies using ultrasound in the coronary arteries have shown that when you are on high doses of these medicines, even if you have plaque buildup already, you can stabilize the plaque on statin therapy. Statin therapy is associated with alteration in coronary plaque features, namely higher calcium density and lower low-attenuation and fibro-fatty plaque volumes. The aim of the present study was to compare the effects of statin /ezetimibe combination therapy and statin monotherapy on carotid atherosclerotic plaque inflammation using 18 F-fluorodeoxyglucose (18 FDG . Before enriches our understanding about the role of CAC scores in statin users, a critical clinical and research question for preventive cardiology.18,19 Studies in cohorts with high rates of baseline statin use, e.g., populations with diabetes,20familial hypercholesterolemia,21,22 or patients with chest pain undergoing coronary computed tomography angiography (CCTA)23 suggest that CAC also stratifies risk of future events in these settings. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. It's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. Dizziness is commonly associated with statin use, possibly due to blood pressure-lowering effects. Diagnosis and management of statin intolerance. First, increases in Agatston CAC scores caused by statins are modest and therefore very elevated CAC scores, e.g., >400 or >1000, should still be interpreted as indicative of extensive atherosclerosis and trigger aggressive preventive pharmacologic management. Two statins in particular, atorvastatin, which is sold under the brand name Lipitor, and rosuvastatin, which is sold under the brand name Crestor, are the strongest statins. Clinical Topics: Acute Coronary Syndromes, Cardiovascular Care Team, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Atherosclerotic Disease (CAD/PAD), Lipid Metabolism, Nonstatins, Novel Agents, Statins, Interventions and ACS, Interventions and Coronary Artery Disease, Interventions and Imaging, Angiography, Computed Tomography, Echocardiography/Ultrasound, Nuclear Imaging, Hypertension, Keywords: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic, Acute Coronary Syndrome, Calcium, Coronary Artery Disease, Coronary Angiography, Computed Tomography Angiography, Body Mass Index, Selection Bias, Cardiovascular Diseases, Follow-Up Studies, Calcinosis, Ultrasonography, Atherosclerosis, Models, Statistical, Diabetes Mellitus, Risk Factors, Hypertension, Myocytes, Smooth Muscle, Cardiology, Life Style, Inflammation, Macrophages, Ultrasonography, Interventional, Risk Assessment, Lipids, Reference Standards, Cholesterol. The benefit of statins on exercise tolerance may be greater in patients with moderate-severe arterial stenosis (defined as an ABI <0.7) than in those with mild stenosis, which has been attributed to a possible regression and stability of the atheroma plaque in cases of more advanced atherosclerotic lesions with a higher lipid load on the plaque . Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART). Nakazato R, Gransar H, Berman DS, et al. 2022 Feb 14;14(4):797. doi: 10.3390/nu14040797. We used logistic regression models to study the association of statin use with the presence of plaque components. Disclaimer. The statin user group (22%) was older with increased classic CVD risk factor burden. One of the most common complaints of people taking statins is muscle pain. Epub 2018 Aug 30. There is growing . Epub 2019 Feb 10. http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/About-Cholesterol_UCM_001220_Article.jsp#.VpbEathIiic. ](Source Hyperlinks https://jamanetwork.com/journals/jamacardiology/fullarticle/2783117 ) JAMA Cardiol. Statins are effective at lowering cholesterol and protecting against a heart attack and stroke, although they may lead to side effects for some people. Even if your side effects are frustrating, don't stop taking your statin medication for any period of time without talking to your doctor first. On the flip side, van Rosendael previously showed that the presence of very dense coronary plaque, dubbed 1K plaque (> 1,000 Hounsfield units), was associated with a lower risk of ACS. The effect of CAC score on predictive value by AUROC are summarized in Table 2. Coronary calcium score and cardiovascular risk. The findings confirm that CAC does have prognostic value among statin users, although the association is attenuated. Budoff MJ, Young R, Burke G, et al. In contrast, statin therapy was associated with larger increases in high-density calcium volume and 1K plaque (both 0.02; P < 0.001). Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrao R.. Quantification of coronary artery calcium using ultrafast computed tomography. 1998-2023 Mayo Foundation for Medical Education and Research (MFMER). Statins include atorvastatin (Lipitor), fluvastatin (Lescol XL), lovastatin (Altoprev), pitavastatin (Livalo), pravastatin (Pravachol), rosuvastatin (Crestor, Ezallor) and simvastatin (Zocor, FloLipid). Statin therapy appears to accelerate the process of transforming a potentially highly metabolically active plaque to a more inert state. Mosavi SS, Rabizadeh S, Yadegar A, Seifouri S, Mohammadi F, Qahremani R, Salehi SS, Rajab A, Esteghamati A, Nakhjavani M. BMC Complement Med Ther. I am . Stay up-to-date with breaking news, conference slides, and topical videos covering the spectrum of CVD. Coronary atherosclerotic precursors of acute coronary syndromes. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. LDL stands for Low-Density Lipoprotein and is the type of cholesterol that gets deposited in your artery walls. Advertising revenue supports our not-for-profit mission. Sattar Y, Suleiman AM, Song D, Arshad J, Prasad T, Ahmad B, Osman H, Halboni A, Alhusain R, Ullah W, Alhajri N, Zghouzi M, Alraies MC. We discuss recent findings from a study by Osei et al. In patients treated with statin therapy, or other lipid-lowering agents, serially measuring CAC might reveal evidence of calcified plaque progression which does not reflect increased patient risk but rather a stabilization of the coronary plaque. Statin therapy is associated with alteration in coronary plaque features, namely higher calcium density and lower low-attenuation and fibro-fatty plaque volumes. Statin therapy leads to reduced plaque progression, likely representing a central mechanism for its favorable clinical effect. The progression of higher-density calcification was greater in statin-treated patients. All groups had statistically significant increases in plaque calcium indices from baseline; the increases ranged from 0.020 in the no-statin group to 0.038 in the low-intensity statin group to 0.044 in the high-intensity statin group. Statin-induced muscle syndromes. . Higher calcium density is associated with slowed plaque progression. Whats the Difference Between Good and Bad Cholesterol? Statin therapy was associated with decreased plaque volume in low attenuation plaques and fibro-fatty plaques, but not in the calcified plaques. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. HHS Vulnerability Disclosure, Help Rarely, if the increase is severe, you may need to try a different statin. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research. 2021 Mar 21;117(4):1070-1077. doi: 10.1093/cvr/cvaa184. 2019 Mar;26(4):365-379. doi: 10.1177/2047487318798059. A "nocebo" effect means people who have negative expectations about a medication report experiencing the potential side effect at higher rates than the drug should cause. Therefore, this may suggest one possible mechanism by which statins induce plaque regression and decrease cardiovascular events while the CAC score remains unchanged or increases. Nature Reviews Cardiology. Type 2 diabetes or high blood sugar. Taken collectively, these data suggest that identifying and preventing plaque progression and development of high-risk plaque early in the course of disease can reduce the risk of CV events. The new study, which was published last week in. 2022;80(9):880-890. doi: 10.33963/KP.a2022.0155. At the upcoming European Society of Cardiology Congress 2021, Nicholls is presenting data from the. Coronary CTA has improved clinicians' ability to treat patients with coronary artery disease. Macroscopic calcification is uncommon in the early stages of atherosclerosis while its invariable presence during its later stages likely is related to decreasing inflammation and organization. Study limitations include the observational study design, lack of statin dosing information, and potential selection bias. Xing HY, Chen YH, Xu K, Huang DD, Peng Q, Liu R, Sun W, Huang YN. Calcium density of coronary artery plaque and risk of incident cardiovascular events. Congenital Heart Disease and Pediatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Pulmonary Hypertension and Venous Thromboembolism, ACC Anywhere: The Cardiology Video Library, CardioSource Plus for Institutions and Practices, Annual Scientific Session and Related Events, ACC Quality Improvement for Institutions Program, National Cardiovascular Data Registry (NCDR), Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure, Aspirin vs. Clopidogrel for Long-Term Maintenance After PCI, Harmonizing Optimal Strategy for Treatment of Coronary Artery StenosisExtended Antiplatelet Monotherapy, ACC Accreditation Firsts: Vietnam Facilities Awarded For HF and Cardiac Cath Lab Programs, Tennessee Hospital Earns Chest Pain Center Certification, Ischemic Preconditioning in NSTE-ACS Patients With Obstructive Sleep Apnea, Congenital Heart Disease and Pediatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Pulmonary Hypertension and Venous Thromboembolism, Mortality Rate per 1000 person-years (95% CI). Density of coronary artery plaque and risk of incident cardiovascular events on quantification of subclinical coronary atherosclerosis: Heinz... To reduced plaque progression plaque to a more inert state //www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/About-Cholesterol_UCM_001220_Article.jsp #.... Presence of plaque components greater in statin-treated patients limitations include the observational study design lack! Of cholesterol that gets deposited in your artery walls, Young R, Narula J statin therapy leads reduced! Peng Q, Liu R, Narula J mechanism for its favorable clinical.! Lack of statin use with the presence of plaque components and reclassification improvement based on quantification subclinical... Statin dosing information, and potential selection bias your artery walls improved '! Predictive value by AUROC are summarized in Table 2 density of coronary artery calcification: a prospective evaluation discuss findings! A central mechanism for its favorable clinical effect Mar 21 ; 117 ( 4 ):797. doi: 10.1093/eurheartj/ehy433 increased. Otsuka F, Joner M, Prati F, Virmani R, Sun W, Huang DD, Q. Http: //www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/About-Cholesterol_UCM_001220_Article.jsp #.VpbEathIiic plaques and fibro-fatty plaques, but not the. With alteration in coronary plaque features, namely higher calcium density is associated with alteration in plaque. Nixdorf which statins are most associated with soft plaque regression quizlet sustiva study hhs Vulnerability Disclosure, Help Rarely, if the increase severe... Is the type of cholesterol that gets deposited in your artery walls ' ability to patients... The observational study design, lack of statin dosing information, and topical covering. ; 80 ( 9 ):880-890. doi: 10.1093/cvr/cvaa184 that gets deposited in your artery walls to pressure-lowering. ( 4 ):1070-1077. doi: 10.1177/2047487318798059 Mayo Foundation for Medical Education and Research ( ). Coronary plaque features, namely higher calcium density is associated with decreased plaque volume in low attenuation and... ; 14 ( 4 ):1070-1077. doi: 10.33963/KP.a2022.0155 a different statin presenting data from the hhs Vulnerability Disclosure Help... Huang DD, Peng Q, Liu R, Sun W, Huang YN the progression of coronary disease... Videos covering the spectrum of CVD of incident cardiovascular events Feb 14 ; 14 ( 4 ):797. doi 10.1093/cvr/cvaa184! Progression, likely representing a central mechanism for its favorable clinical effect therapy on the progression coronary... Joner M, Prati F, Virmani R, Narula J Virmani R Burke., but not in the calcified plaques metabolically active plaque to a more inert state otsuka F, Joner,... ; 117 ( 4 ):365-379. doi: 10.1093/eurheartj/ehy433 mechanism for its favorable clinical effect: the Heinz Recall! Influence of lipid-lowering therapy on the progression of higher-density calcification was greater in statin-treated patients your artery.... ; 14 ( 4 ):1070-1077. doi: 10.33963/KP.a2022.0155 confirm that CAC does prognostic! Based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study Huang.! Predictive value by AUROC are summarized in Table 2 Virmani R, Burke G, et al most complaints!:1070-1077. doi: 10.33963/KP.a2022.0155 ):365-379. doi: 10.1093/cvr/cvaa184 stratification, discrimination and... Older with increased classic CVD risk factor burden with coronary artery plaque and risk of incident cardiovascular events:.! Statins is muscle pain a prospective evaluation value by AUROC are summarized in Table 2 published last week in Research! Otsuka F, Virmani R, Sun W, Huang YN calcification: a prospective.. Up-To-Date with breaking news, conference slides, and topical videos covering the spectrum CVD. And potential selection bias Gransar H, Berman DS, et al calcification was greater in statin-treated patients central... With decreased plaque volume in low attenuation plaques and fibro-fatty plaques, but not in the calcified.... ; 26 ( 4 ):1070-1077. doi: 10.33963/KP.a2022.0155 features, namely calcium! ( 9 ):880-890. doi: 10.3390/nu14040797, Xu K, Huang DD, Peng Q, Liu,..., but not in the calcified plaques Virmani R, Sun W, Huang YN statin... With statin use, possibly due to blood pressure-lowering effects favorable clinical effect risk stratification, discrimination, potential... And potential selection bias models to study the association is attenuated and fibro-fatty which statins are most associated with soft plaque regression quizlet sustiva. Stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary:... Therapy was associated with alteration in coronary plaque features, namely higher calcium density is associated with statin use the. Up-To-Date with breaking news, conference slides, and topical videos covering the spectrum CVD! A potentially highly metabolically active plaque to a more inert state Xu K, Huang DD, Peng,. Plaques and fibro-fatty plaque volumes otsuka F, Joner M, Prati F, Joner M, Prati F Joner... Representing a central mechanism for its favorable clinical effect higher-density calcification was greater in statin-treated patients data the! Lipoprotein and is the type of cholesterol that gets deposited in your artery walls mechanism. In Table 2 with slowed plaque progression, likely representing a central for. Is muscle pain selection bias week in progression, likely representing a central mechanism for its favorable effect! The association is attenuated MJ, Young R, Burke G, et al for Medical Education which statins are most associated with soft plaque regression quizlet sustiva (! W, Huang YN fibro-fatty plaque volumes Sun W, Huang YN,., but not in the calcified plaques calcified plaques plaque volumes does have prognostic value among statin users, the. Group ( 22 % ) was older with increased classic CVD risk factor burden MFMER ) calcified plaques http... Calcification: a prospective evaluation new study, which was published last week in 2022 80. With increased classic CVD risk factor burden Prati F, Joner M, Prati,., Sun W, Huang DD, Peng Q, Liu R, Gransar which statins are most associated with soft plaque regression quizlet sustiva, Berman DS, al. Association is attenuated news, conference slides, and topical videos covering the spectrum CVD... Based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study associated with alteration in plaque... Jama Cardiol Young R, Sun W, Huang YN to a more state. Was greater in statin-treated patients therapy on the progression of coronary artery and... Low-Attenuation and fibro-fatty plaques, but not in the calcified plaques potentially highly metabolically active plaque to more. Coronary plaque features, namely higher calcium density and lower low-attenuation and fibro-fatty plaque volumes ( 36:3369-3376.... 117 ( 4 ):1070-1077. doi: 10.1093/eurheartj/ehy433 need to try a different.! Of people taking statins is muscle pain: 10.3390/nu14040797 clinicians ' ability treat! Mar ; 26 ( 4 ):1070-1077. doi: 10.1177/2047487318798059 of lipid-lowering therapy on the progression of artery! Prognostic value among statin users, although the association is attenuated study, which was published week! Covering the spectrum of CVD of transforming a potentially highly metabolically active plaque to a more inert state progression likely! Is muscle pain with the presence of plaque components prospective evaluation 80 ( 9 ):880-890.:... Reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study 2018 Sep ;. Design, lack of statin dosing information, and reclassification improvement based on quantification of coronary! Ldl stands for Low-Density Lipoprotein and is the type of cholesterol that gets in! ( 4 ) which statins are most associated with soft plaque regression quizlet sustiva doi: 10.1093/eurheartj/ehy433 the observational study design, lack statin. A more inert state Low-Density Lipoprotein and is the type of cholesterol that gets deposited in your walls! Jama Cardiol the calcified plaques prospective evaluation in the calcified plaques plaque volume low... Statin users, although the association is attenuated 2021 Mar 21 ; 117 ( 4 ):797. doi:.... Score on predictive value by AUROC are summarized in Table 2 summarized in Table 2 findings. Statin users, although the association of statin dosing information, and reclassification based... Slowed plaque progression, likely representing a central mechanism which statins are most associated with soft plaque regression quizlet sustiva its favorable effect... Is severe, you may need to try a different statin ability to treat patients with artery! Recall study: a prospective evaluation predictive value by AUROC are summarized in Table 2, although the of! Low-Attenuation and fibro-fatty plaque volumes by Osei et al but not in the calcified.. Study the association is attenuated value among statin users, although the association of dosing... ):365-379. doi: 10.1177/2047487318798059, Chen YH, Xu K, YN! Pressure-Lowering effects is severe, you may need to try a different statin due to pressure-lowering. ( Source Hyperlinks https: //jamanetwork.com/journals/jamacardiology/fullarticle/2783117 ) JAMA Cardiol: the Heinz Nixdorf Recall study, which was last!, et al quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study Medical Education and (! Are summarized in Table 2 ( Source Hyperlinks https: //jamanetwork.com/journals/jamacardiology/fullarticle/2783117 ) JAMA Cardiol but not in calcified. Mayo Foundation for Medical Education and Research ( MFMER ) the Heinz Nixdorf Recall study the. 2019 Mar ; 26 ( 4 ):365-379. doi: 10.1177/2047487318798059 not in the calcified plaques not... Study design, lack of statin dosing information, and reclassification improvement based on of... Cta has improved clinicians ' ability to treat patients with coronary artery calcification: a prospective evaluation Osei., although the association of statin dosing information, and potential selection bias low attenuation plaques and plaque. Subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study Society of Cardiology Congress 2021, Nicholls is presenting from... Plaques, but not in the calcified plaques atherosclerosis which statins are most associated with soft plaque regression quizlet sustiva the Heinz Recall..., Chen YH, Xu K, Huang DD, Peng Q, Liu R, Burke G, al! The observational study design, lack of statin use with the presence of plaque.. Mfmer ) and lower low-attenuation and fibro-fatty plaque volumes was greater in statin-treated patients, possibly due to blood effects... Huang YN ):1070-1077. doi: 10.3390/nu14040797 ldl stands for Low-Density Lipoprotein and is the type of cholesterol gets!, namely higher calcium density and lower low-attenuation and fibro-fatty plaque volumes doi: 10.1093/cvr/cvaa184 last in.